Results

Total Results: 1,541 records

Showing results for "months".

61. Kidney-Stones-Draft-Appendi-C (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendi-c.xlsx
    January 01, 2024 - to 36 months Based on plain x-ray at every 6 month interval from 6 months to 36 months n/N (%) at 3 … None Mean 18 months (range 6 to 32 months) NR NR NR NR NR NR Among patients without stones at baseline … None 2 years Adherence to lemon juice: 79% at 6 months, 68% at 1 year, 48% at two years. … None 6 months to 1 year Measured by pill counts but actual adherence levels NR. … None Mean 18 months (range 6 to 32 months) NR NR NR NR NR NR NR NR NR NR Two blinded observers agreed

62. Ear-Infection Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_executive.pdf
    May 01, 2013 - of less than 3 months. … TT improved hearing through 9 months after surgery compared with watchful waiting (3–6 months: 8.8 … dB; 6–9 months: 4.2 dB) (high strength of evidence); TT improved hearing by 10 dB at 4 to 6 months … Adenoidectomy was superior to no treatment for hearing in one study at 6 months but not at 12 months … or in median days with hearing loss at 3 months.

63. Management of Suicidal Thoughts and Behaviors in Youth: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-exe-sum.pdf
    April 01, 2025 - ideation (SI), and non-suicidal self-injury (NSSI) when administered as a multicomponent treatment over 6 months … to 12 months. … The median followup was 10.76 months, ranging from 1 to 168 months. … to 168 months. … Two RCTs40, 41 failed to find a difference on suicidal outcomes at 12- months between Youth Nominated

64. Carbohydrate-Intake-Prepub-Final-Research-Table-Da (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-prepub-final-research-table-da.xlsx
    January 01, 2019 - of age Mean age, months (SD): 4.5 (0.5) vs. 4.5 (0.5) % female: 42% vs. 45% Race/ethnicity: NR Birth … B, 6 months 2941 (525) vs. 2941 (497) 9 months 3472 (498) vs. 3432 (538) Mean, g (SD) A vs. … B, 6 months 87.6 (20.9) vs. 83.1 (16.8) 9 months 113.6 (20.6) vs. 103.4 (18.5), p<0.001 NR NR NR NR … B, 6 months 11.7 (3.0) vs. 13.1 (4.0) 9 months 15.9 (3.6) vs. 21.5 (5.7) NR Mean, g (SD) A vs. … B, 6 months 32.3 (6.0) vs. 33.1 (6.7) 9 months 32.8 (5.4) vs. 33.7 (6.9) NR Latva-Pukkila, 2010 Median

65. Febrile-Infants-Diagnosis-Management Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/febrile-infants-diagnosis-management_executive.pdf
    March 01, 2012 - How do these findings vary by age within the age range 0–3 months? … How do these findings vary by age within the age range 0 to 3 months? … These studies included children with age range of 0–3 months. … Incidence of serious infection in infants under age two months with fever. … Diagnosis and Management of Febrile Infants (0–3 Months).

66. Reduction in Medication Use after Bariatric Surgery (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/bariatric-surgery_research.pdf
    June 01, 2010 - Medication use declined significantly by 3 months. … ) Have 12 months of continuous coverage, including pharmacy coverage, after the index date Be … The primary comparisons were medication usage at 3, 6, and 12 months after surgery in comparison to … The curves diverged by 3 months after surgery. … (and % decrease) Count at 6 months (and % decrease) Count at 12 months(and % decrease) Diabetes

67. REQUEST FOR TASK ORDER (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
    April 01, 2010 - Denominator: Prospective: Subjects with at least 9 months out of the hospital during the 14 months … Denominator: Prospective: Subjects with at least 9 months out of the hospital during the 14 months … Denominator: Prospective: Subjects with at least 9 months out of the hospital during the 14 months … prospectively or 14 months retrospectively depending on the cohort. … Death date (index date) Diagnosis date: -14 months -30 days 14 months (or death) Diagnosis date

68. Microsoft Word - finbody.doc (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
    January 01, 2007 - months. … Patients were followed at 1 month, 3 months, and 6 months after the end of a run-in period or after … The studies followed patients from 6 months to 48 months. … to 84 months. … The mean follow up times in these studies ranged from 4 months to 56 months.

69. Rapid Evidence Product Addressing Social Isolation To Improve the Health of Older Adults A Rapid Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-social-isolation-older-adults-final.pdf
    February 01, 2019 - at 6 months or 12 months • The overall group x time score for perceived togetherness (Social Provisions … Data collected at baseline, 3 months, and 6 months (after cross- over): • Frailty (Check-List 15) … before intervention, just after it, and 6 months later. … on loneliness at 9 months (20-item UCLA loneliness scale, version 3) At 9 months: • Perceived … were from 26 months.

70. MEDICAL MANAGEMENT OF CONGESTIVE HEART FAILURE AND THE EFFECTIVENESS OF ISOSORBIDE DINITRATE AND HYDRALAZINE (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/congestive-heart-failure-medicines_research.pdf
    March 01, 2010 - We chose to use three time intervals: 1-4 months, 5-12 months, and >12 months after HF diagnosis. … There were no significant associations between H-ISDN exposure initiated at 1–4 months and 5–12 months … , Hispanics with initiation at 5–12 months and >12 months, and Whites with initiation >12 months (Figure … Hazard ratios significantly >1.0 were seen when H-ISDN was initiated >12 months after the diagnosis … However, less than 40% of patients had been started on this combination within six months of their HF

71. Tympanostomy Tubes in Children With Otitis Media (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-executive-170523.pdf
    May 01, 2017 - and symptoms of an acute infection.1,2 OME is defined as chronic OME, if effusion persists for 3 months … Similarly, hearing thresholds obtained between 12 and 24 months where were classified “late”. … Figure E shows the topology of the network for early hearing thresholds at 1 to 3 months. … The improvement by early (mean age 3 months) compared to delayed (mean age 40.8 months or not at all … months or persistent effusion lasting at least 2 months), percent of children with no recurrent AOM

72. Back-Pain-Imaging Clinician (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-imaging_clinician.pdf
    April 01, 2016 - related quality of life, and falls in the past 3 weeks; these outcomes were assessed at 3, 6, and 12 months … KEY FINDINGS »» At 12 months, neither the early radiograph group nor the early MRI/ CT group differed … »» Patients in the early radiograph group had lower numerical scores for leg pain at 3, 6, and 12 months … early MRI/CT, when com- pared with the no early imaging group, reported lower leg pain intensity at 6 months … and better health status at 12 months, but these differences were small and clinically unimportant

73. Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
    January 01, 2010 - At 30-months, DES patients had lower unadjusted rates of death (12.9% vs. 17.9%), MI (7.3 vs. 10.0/ … The DES survival benefit was observed in all subgroups analyzed and persisted throughout 30- months’ … The adjusted mortality difference was statistically significant in the initial six months post-PCI, … This result was driven by lower MI rates in DES patients during the first 12-months post-PCI (Figure … 2b), with no difference between 12 and 30-months of follow-up.

74. Diagnosis and Management of Febrile Infants (0–3 Months) | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/febrile-infants-diagnosis-management/research

75. Arthritis and Nontraumatic Joint Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
    January 01, 2012 - Fifty-foot walk pain improved 47% and 70% from baseline at 6 and 12 months, respectively. … declining at 12 months’ followup (p=0.02). … At 3 months, patients taking placebo who were not responding were given tofacitinib. … At 6 months, all placebo-assigned patients were advanced to tofacitinib. … Placebo patients were given tofacitinib at 3 months.

76. Omega-3 Fatty Acids and Maternal and Child Health: An Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_executive.pdf
    October 01, 2016 - DHA, DHA+EPA, DHA+AA), follow-up time (i.e. birth, 12 months of age), and population (i.e. pregnant … on VEP at 4 months (WMD -0.06 [-0.12, 0.01]; I2=1.7%) and 6 months corrected age (WMD -0.04[ -0.09 … At 4 months follow- up, the pooled effect size for behavioral measurements was significant in favor … The pooled difference in MDI scores at 18 months was not significant when 3 RCTs were pooled. … but not at 2 months, when assessed using VEP.

77. Pediatric Quality Measures Program 3.0: An Evidence Map of Measures for Vision, Hearing, and Developmental Screening and Followup (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/pqmp-protocol.pdf
    April 01, 2014 - Developmental screening is recommended in infancy (at 9 months) and early childhood (at 18 and 30 months … ), with screening for autism spectrum disorder in early childhood (at 18 and 24 months). … Perform risk assessment with appropriate action to follow if positive (at 4, 6, and 9 months) … (at 18 and 30 months) --- --- Autism Spectrum Disorder Screening --- Perform AUTISM SCREEN (at … 18 and 24 months) --- --- Evidence-based Practice Center Technical Brief Protocol Project

78. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_executive.pdf
    July 01, 2009 - Key Question 1.What is the effect of RFA on short-term (6 to 12 months) and long-term (>12 months) rhythm … evidence showing no statistically significant difference in the risk of cerebrovascular events at 12 months … This study of patients with PAF found no significant difference at 12 months followup in the recurrence … The only exception was the diagnosis of PV stenosis, which was routinely screened for at around 3 months … In addition, followup durations longer than the typical 6 to 12 months observed in the current literature

79. Transparency of Reporting Requirements: Management of Infertility (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-infertility_research-protocol.pdf
    September 02, 2016 - of regular intercourse for women under 35, or 6 months for women 35 and older (alternate definitions … of life if live birth occurs o Long-term § 12 months or more from completion of treatment (no live … of regular intercourse for women under 35, or 6 months for women 35 and older (alternate definitions … of regular intercourse for women under 35, or 6 months for women 35 and older (alternate definitions … of regular intercourse for women under 35, or 6 months for women 35 and older (alternate definitions

80. CER 229 Evidence Summary: Opioid Treatments for Chronic Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-229-opioid-treatments-chronic-pain-evidence-summary.pdf
    April 01, 2020 - ), intermediate-term (6 to <12 months), and long-term followup (≥12 months); with Key Questions on … ), intermediate-term followup (6 to <12 months), and long-term followup (≥12 months)? … ), intermediate-term followup (6 to <12 months), and long-term followup (≥12 months)? … ), intermediate-term followup (6 to <12 months), and long-term followup (≥12 months)? … All trials were 6 months in duration or less, with most (87.5%) trials 3 months or less.